You are here: Industry Insights > Mayne Pharma

News List

Metrics Contract Services Expands Business Development Team contractpharma
October 22, 2020
Lettie Kirk has joined Metrics Contract Services (Metrics), a division of Mayne Pharma, as business development executive.
Mayne Pharma Submits NDA to FDA for E4/DRSP contractpharma
April 17, 2020
Development and manufacturing partner Mithra can synthesise E4 at scale through a complex plant-based production process.
Mayne Pharma Launches Lexette Foam 0.05% in the US americanpharmaceuticalreview
February 15, 2019
Mayne Pharma has announced the launch of LEXETTE (halobetasol propionate) Foam 0.05% in the United States. LEXETTE, the conditionally-acceptable trade name for halobetasol foam is a new formulation of halobetasol...
FDA clears Zydus Cadila to market generic versions of Mayne Pharma's Doryx, Takeda's Uloric firstwordpharma
December 25, 2018
Zydus Cadila announced Monday that the FDA granted the company final approval to market the delayed-release formulation of doxycycline hyclate to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.
Mayne pharma launches generic version of Monodox in Australia biospectrumasia
March 19, 2018
The drug is indicated for the treatment of a number of infections, including adjunctive therapy in severe acne
Mayne Pharma Acquires Rights to Generic Duragesic® Patch americanpharmaceuticalreview
March 13, 2017
Mayne Pharma has acquired the rights to the fentanyl transdermal delivery system (TDS), 25 mcg/hr, 50 mcg/hr, 75 mcg/hr and 100 mcg/hr from Par Pharmaceutical Inc. (Par).
Mayne Pharma Acquires Pars’ Generic Pain Patch contractpharma
March 10, 2017
Will assume Par’s manufacturing and supply agreement with Corium
Mayne Pharma Enters License/Supply Pact contractpharma
March 01, 2017
Mayne Pharma Inc. has entered into a long-term, exclusive license and supply agreement with Mithra Pharmaceuticals SA for Myring, an intravaginal hormonal contraceptive delivery device.
Mayne Pharma Launches Methylphenidate Extended-Release 60mg Capsules in the United States americanpharmaceuticalreview
February 22, 2017
Mayne Pharma has announced the launch of methylphenidate extended-release capsules, 60mg, in the United States.